Episode
New Pill Targets Resistant Breast Cancer | Detroit News
- Published
- Sep 11, 2026
- Duration seconds
- 100
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/532ca3f8355edcbf
Actions
POST https://stenobird.com/v1/public/podcasts/detroit-news-today-2-min-news-the-daily-news-now-7476185/episodes/new-pill-targets-resistant-breast-cancer-detroit-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/detroit-news-today-2-min-news-the-daily-news-now-7476185/new-pill-targets-resistant-breast-cancer-detroit-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
A breakthrough pill called Etcamah is showing promise for advanced estrogen-driven breast cancer that resists standard treatments. Designed to target specific genetic mutations—like those in the ESR1 gene—that let cancer cells evade therapy, it’s paired with a revolutionary blood test that spots resistance before scans can detect it. This early intervention could dramatically improve outcomes. The FDA has granted accelerated approval based on its ability to delay disease progression, though longer-term survival data is still pending. For patients with treatment-resistant cancer, this could be a major new weapon in the fight. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/532ca3f8355edcbf